Pharsight

Drugs that contain Olodaterol Hydrochloride

1. Striverdi Respimat patents expiration

STRIVERDI RESPIMAT's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7491719 BOEHRINGER INGELHEIM Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
Nov, 2023

(5 months ago)

US7056916 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Dec, 2023

(4 months ago)

US7220742 BOEHRINGER INGELHEIM Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
May, 2025

(1 year, 21 days from now)

US7727984 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Jan, 2027

(2 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7246615 BOEHRINGER INGELHEIM Atomising nozzle and filter and spray generating device
May, 2016

(7 years ago)

US7104470 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US5964416 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US6726124 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US6176442 BOEHRINGER INGELHEIM Device for mounting a component exposed to a pressurized fluid
Oct, 2016

(7 years ago)

US6453795 BOEHRINGER INGELHEIM Locking mechanism for a spring-actuated device
Dec, 2016

(7 years ago)

US6149054 BOEHRINGER INGELHEIM Mechanical counter for a metering apparatus
Dec, 2016

(7 years ago)

US6846413 BOEHRINGER INGELHEIM Microstructured filter
Aug, 2018

(5 years ago)

US6977042 BOEHRINGER INGELHEIM Microstructured filter
Aug, 2018

(5 years ago)

US7802568 BOEHRINGER INGELHEIM Cartridge for a liquid
Feb, 2019

(5 years ago)

US6988496 BOEHRINGER INGELHEIM Cartridge for a liquid
Feb, 2020

(4 years ago)

US7988001 BOEHRINGER INGELHEIM Container provided with a pressure equalization opening
Aug, 2021

(2 years ago)

US7786111 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Nov, 2023

(5 months ago)

US8044046 BOEHRINGER INGELHEIM Medicaments for the treatment of chronic obstructive pulmonary disease
Nov, 2023

(5 months ago)

US7284474 BOEHRINGER INGELHEIM Piston-pumping system having o-ring seal properties
Aug, 2024

(4 months from now)

US8034809 BOEHRINGER INGELHEIM Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
May, 2025

(1 year, 21 days from now)

US7896264 BOEHRINGER INGELHEIM Microstructured high pressure nozzle with built-in filter function
May, 2025

(1 year, 1 month from now)

US7396341 BOEHRINGER INGELHEIM Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Oct, 2026

(2 years from now)

US9027967 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2027

(2 years from now)

US7837235 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2028

(3 years from now)

US8733341 BOEHRINGER INGELHEIM Atomizer and method of atomizing fluid with a nozzle rinsing mechanism
Oct, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Jul 31, 2019

NCE-1 date: 31 July, 2018

Market Authorisation Date: 31 July, 2014

Treatment: Treatment of chronic obstructive pulmonary disease (copd), chronic bronchitis or emphysema

Dosage: SPRAY, METERED;INHALATION

More Information on Dosage

STRIVERDI RESPIMAT family patents

Family Patents